VCT220
This is an Open-label, Non-randomized Study to Assess the Pharmacokinetics (PK) of VCT220 in Healthy Volunteers When Administered With Rifampin or Itraconazole
Vincentage Pharma Co · Phase 1 · Completed · Enrollment 32
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Experimental Arm | n/r | n/r | n/r | n/r |
Not shown
- Experimental Arm: endpoint not reported